2017Zhongguo jiceng yiyaoRequires access

The efficacy of amiodarone combined with enalapril in cardioversion of atrial fibrillation and maintenance of sinus rhythm in patients with hypertension and paroxysmal atrial fibrillation

Jinyan Zhang

Open publisher page 0 citations

Abstract

Objective To observe the efficacy of amiodarone combined with enalapril in cardioversion of atrial fibrillation and maintenance of sinus rhythm in patients with hypertension and paroxysmal atrial fibrillation. Methods 60 patients with hypertension and paroxysmal atrial fibrillation were selected as study objects.They were divided into study group and control group according to the random number table, 30 cases in each group.The control group was treated with amiodarone combined with nifedipine, the observation group was given amiodarone combined with enalapril.After 1, 3 and 7 days of treatment, the rates of cardioversion of atrial fibrillation were observed.The rates of maintenance of sinus rhythm were observed after 3, 6, 9 and 12 months of treatment.The left atrial diameter was calculated by echocardiography.The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were detected by blood pressure monitor. Results The rates of cardioversion of atrial fibrillation in the study group and the control group after 3 and 7 days of treatment were 86.67% and 63.33%, 100.00% and 86.67%, respectively, the differences were statistically significant (all P<0.05). The rates of maintenance of sinus rhythm in the study group and the control group after 6, 9, and 12 months of treatment were 83.33% and 57.69%, 80.00% and 53.85%, 76.67% and 50.00%, the differences were statistically significant (χ2=4.487, 4.368, 4.314, all P<0.05). There were no significant differences in SBP and DBP between the study group and the control group at 3, 6, 9 and 12 months after treatment (all P<0.05). The left atrial diameter of the study group after 12 months of treatment was (36.73±2.66)mm, which was significantly lower than (38.78±2.64)mm in the control group, the difference was statistically significant (P<0.05). Conclusion Amiodarone combined with enalapril can improve the conversion rate and the rate of sinus rhythm maintenance in patients with hypertension and paroxysmal atrial fibrillation, and effectively control the atrial enlargement and improve the clinical prognosis. Key words: Hypertension; Atrial fibrillation; Enalapril; Amiodarone

About this research paper

What this paper is about

Objective To observe the efficacy of amiodarone combined with enalapril in cardioversion of atrial fibrillation and maintenance of sinus rhythm in patients with hypertension and paroxysmal atrial fibrillation. Methods 60 patients with hypertension and paroxysmal atrial fibrillation were selected as study objects.They were divided into study group and control group according to the random number table, 30 cases in each group.The control group was treated with amiodarone combined with nifedipine, the observation group was given amiodarone combined with enalapril.After 1, 3 and 7 days of treatment, the rates of cardioversion of atrial fibrillation were observed.The rates of maintenance of sinus rhythm were observed after 3, 6, 9 and 12 months of treatment.The left atrial diameter was calculated by echocardiography.The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were detected by blood pressure monitor. Results The rates of cardioversion of atrial fibrillation in the study group and the control group after 3 and 7 days of treatment were 86.67% and 63.33%, 100.00% and 86.67%, respectively, the differences were statistically significant (all P<0.05). The rates of maintenance of sinus rhythm in the study group and the control group after 6, 9, and 12 months of treatment were 83.33% and 57.69%, 80.00% and 53.85%, 76.67% and 50.00%, the differences were statistically significant (χ2=4.487, 4.368, 4.314, all P<0.05). There were no significant differences in SBP and DBP between the study group and the control group at 3, 6, 9 and 12 months after treatment (all P<0.05). The left atrial diameter of the study group after 12 months of treatment was (36.73±2.66)mm, which was significantly lower than (38.78±2.64)mm in the control group, the difference was statistically significant (P<0.05). Conclusion Amiodarone combined with enalapril can improve the conversion rate and the rate of sinus rhythm maintenance in patients with hypertension and paroxysmal atrial fibrillation, and effectively control the atrial enlargement and improve the clinical prognosis. Key words: Hypertension; Atrial fibrillation; Enalapril; Amiodarone

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy of amiodarone combined with enalapril in cardioversion of atrial fibrillation and maintenance of sinus rhythm in patients with hypertension and paroxysmal atrial fibrillation. Methods 60 patients with hypertension and paroxysmal atrial fibrillation were selected as study objects.They were divided into study group and control group according to the random number table, 30 cases in each group.The control group was treated with amiodarone combined with nifedipine, the observation group was given amiodarone combined with enalapril.After 1, 3 and 7 days of treatment, the rates of cardioversion of atrial fibrillation were observed.The rates of maintenance of sinus rhythm were observed after 3, 6, 9 and 12 months of treatment.The left atrial diameter was calculated by echocardiography.The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were detected by blood pressure monitor. Results The rates of cardioversion of atrial fibrillation in the study group and the control group after 3 and 7 days of treatment were 86.67% and 63.33%, 100.00% and 86.67%, respectively, the differences were statistically significant (all P<0.05). The rates of maintenance of sinus rhythm in the study group and the control group after 6, 9, and 12 months of treatment were 83.33% and 57.69%, 80.00% and 53.85%, 76.67% and 50.00%, the differences were statistically significant (χ2=4.487, 4.368, 4.314, all P<0.05). There were no significant differences in SBP and DBP between the study group and the control group at 3, 6, 9 and 12 months after treatment (all P<0.05). The left atrial diameter of the study group after 12 months of treatment was (36.73±2.66)mm, which was significantly lower than (38.78±2.64)mm in the control group, the difference was statistically significant (P<0.05). Conclusion Amiodarone combined with enalapril can improve the conversion rate and the rate of sinus rhythm maintenance in patients with hypertension and paroxysmal atrial fibrillation, and effectively control the atrial enlargement and improve the clinical prognosis. Key words: Hypertension; Atrial fibrillation; Enalapril; Amiodarone

Key concepts: Medicine, Atrial fibrillation, Amiodarone, Sinus rhythm, Cardioversion, Cardiology, Internal medicine, Enalapril

Related papers

Back to paper searchBrowse research topicsOriginal source
The efficacy of amiodarone combined with enalapril in cardioversion of atrial fibrillation and maintenance of sinus rhythm in patients with hypertension and paroxysmal atrial fibrillation — Research Paper | ScholarLens